102 related articles for article (PubMed ID: 30262802)
1. A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.
Voeltzel T; Flores-Violante M; Zylbersztejn F; Lefort S; Billandon M; Jeanpierre S; Joly S; Fossard G; Milenkov M; Mazurier F; Nehme A; Belhabri A; Paubelle E; Thomas X; Michallet M; Louache F; Nicolini FE; Caron de Fromentel C; Maguer-Satta V
Cell Death Dis; 2018 Sep; 9(10):1011. PubMed ID: 30262802
[TBL] [Abstract][Full Text] [Related]
2. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
3. Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitors.
Komorowski L; Dabkowska A; Madzio J; Pastorczak A; Szczygiel K; Janowska M; Fidyt K; Bielecki M; Hunia J; Bajor M; Stoklosa T; Winiarska M; Patkowska E; Firczuk M
Hemasphere; 2024 Mar; 8(3):e56. PubMed ID: 38486859
[TBL] [Abstract][Full Text] [Related]
4. BMP signaling in cancer stemness and differentiation.
Zhou W; Yan K; Xi Q
Cell Regen; 2023 Dec; 12(1):37. PubMed ID: 38049682
[TBL] [Abstract][Full Text] [Related]
5. TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax.
Tyagi A; Jaggupilli A; Ly S; Yuan B; El-Dana F; Hegde VL; Anand V; Kumar B; Puppala M; Yin Z; Wong STC; Mollard A; Vankayalapati H; Foulks JM; Warner SL; Daver N; Borthakur G; Battula VL
Leukemia; 2024 Jan; 38(1):82-95. PubMed ID: 38007585
[TBL] [Abstract][Full Text] [Related]
6. An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers.
Guyot B; Clément F; Drouet Y; Schmidt X; Lefort S; Delay E; Treilleux I; Foy JP; Jeanpierre S; Thomas E; Kielbassa J; Tonon L; Zhu HH; Saintigny P; Gao WQ; de la Fouchardiere A; Tirode F; Viari A; Blay JY; Maguer-Satta V
Cancer Res Commun; 2023 Sep; 3(9):1966-1980. PubMed ID: 37707389
[TBL] [Abstract][Full Text] [Related]
7. Bone Morphogenetic Protein-4 Impairs Retinal Endothelial Cell Barrier, a Potential Role in Diabetic Retinopathy.
Darwish NHE; Hussein KA; Elmasry K; Ibrahim AS; Humble J; Moustafa M; Awadalla F; Al-Shabrawey M
Cells; 2023 Apr; 12(9):. PubMed ID: 37174679
[TBL] [Abstract][Full Text] [Related]
8. Identification of the immunosuppressive effect of γδ T cells correlated to bone morphogenetic protein 2 in acute myeloid leukemia.
Liang S; Dong T; Yue K; Gao H; Wu N; Liu R; Chang Y; Hao L; Hu L; Zhao T; Jiang Q; Huang XJ; Liu J
Front Immunol; 2022; 13():1009709. PubMed ID: 36325350
[TBL] [Abstract][Full Text] [Related]
9. The Bone Marrow Microenvironment in B-Cell Development and Malignancy.
Hughes AM; Kuek V; Kotecha RS; Cheung LC
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565219
[TBL] [Abstract][Full Text] [Related]
10. High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes.
Fernández-Sevilla LM; Valencia J; Ortiz-Sánchez P; Fraile-Ramos A; Zuluaga P; Jiménez E; Sacedón R; Martínez-Sánchez MV; Jazbec J; Debeljak M; Fedders B; Stanulla M; Schewe D; Cario G; Minguela A; Ramírez M; Varas A; Vicente Á
Blood; 2022 Jun; 139(22):3303-3313. PubMed ID: 35313334
[TBL] [Abstract][Full Text] [Related]
11. Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer.
Guyot B; Lefort S; Voeltzel T; Pécheur EI; Maguer-Satta V
Front Cell Dev Biol; 2021; 9():787989. PubMed ID: 35047500
[TBL] [Abstract][Full Text] [Related]
12. Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies.
Mancini SJC; Balabanian K; Corre I; Gavard J; Lazennec G; Le Bousse-Kerdilès MC; Louache F; Maguer-Satta V; Mazure NM; Mechta-Grigoriou F; Peyron JF; Trichet V; Herault O
Front Immunol; 2021; 12():766275. PubMed ID: 34858421
[TBL] [Abstract][Full Text] [Related]
13. High-throughput measurements of bone morphogenetic protein/bone morphogenetic protein receptor interactions using biolayer interferometry.
Khodr V; Machillot P; Migliorini E; Reiser JB; Picart C
Biointerphases; 2021 Jun; 16(3):031001. PubMed ID: 34241280
[TBL] [Abstract][Full Text] [Related]
14. Roles of Melatonin in Goat Hair Follicle Stem Cell Proliferation and Pluripotency Through Regulating the Wnt Signaling Pathway.
Zhang W; Wang N; Zhang T; Wang M; Ge W; Wang X
Front Cell Dev Biol; 2021; 9():686805. PubMed ID: 34150780
[TBL] [Abstract][Full Text] [Related]
15. Direct reprogramming of human smooth muscle and vascular endothelial cells reveals defects associated with aging and Hutchinson-Gilford progeria syndrome.
Bersini S; Schulte R; Huang L; Tsai H; Hetzer MW
Elife; 2020 Sep; 9():. PubMed ID: 32896271
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
17. Loss of Myeloid BMPR1a Alters Differentiation and Reduces Mouse Prostate Cancer Growth.
Ihle CL; Straign DM; Provera MD; Novitskiy SV; Owens P
Front Oncol; 2020; 10():357. PubMed ID: 32318332
[TBL] [Abstract][Full Text] [Related]
18. The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remission.
Jeanpierre S; Arizkane K; Thongjuea S; Grockowiak E; Geistlich K; Barral L; Voeltzel T; Guillemin A; Gonin-Giraud S; Gandrillon O; Nicolini FE; Mead AJ; Maguer-Satta V; Lefort S
Haematologica; 2021 Jan; 106(1):111-122. PubMed ID: 32001529
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
